Nicholas Hertz

President & CEO at Montara Therapeutics.

Raised on Montara Therapeutics filings

$20M

of $20M offered across 1 Form D filing

Company

Biotech · San Francisco, CA

Brain-targeted drugs for neurological disease

Brain-targeted drugs for neurological disease

Montara Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Mar 13, 2025	Equity	$20M/ $20M	Form D

Also named on Montara Therapeutics filings